Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
145.13
Aug 21 • 3:59 PM ET Dollar change+11.81 Percentage change(8.86%)
Aftermarket Close
145.80
Aftermarket • 7:59 PM ET Dollar change+0.67 Percentage change(0.46%)
Aug 21, 10:01 AMModerna rebounds on momentum from melanoma mRNA vaccine Phase 3 success
Index
S&P 500
Market Cap
57.94B
Enterprise Value
54.09B
Income
-3.15B
Sales
2.23B
Book/sh
16.94
Cash/sh
12.87
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
4700
IPO
Dec 07, 2018
P/E
-
Forward P/E
-
PEG
-
P/S
26.01
P/B
8.56
P/C
11.28
P/FCF
-
EV/EBITDA
-
EV/Sales
24.28
Quick Ratio
2.18
Current Ratio
2.29
Debt/Eq
0.19
LT Debt/Eq
0.18
Option/Short
Yes / Yes
EPS (ttm)
-7.98
EPS next Y
-4.88
EPS next Q
-1.16
EPS this Y
-17.04%
EPS next Y
42.58%
EPS next 5Y
27.68%
EPS past 3/5Y
- -29.93%
Sales past 3/5Y
-53.32% 19.33%
EPS Y/Y TTM
-6.22%
Sales Y/Y TTM
-27.62%
EPS Q/Q
7.60%
Sales Q/Q
2.11%
Insider Own
8.51%
Insider Trans
-2.45%
Inst Own
79.88%
Inst Trans
-2.19%
ROA
-27.43%
ROE
-39.00%
ROIC
-39.41%
Gross Margin
12.57%
Oper. Margin
-149.01%
Profit Margin
-141.43%
SMA20
99.99%
SMA50
114.68%
SMA200
197.84%
Trades
Shs Outstand
399.00M
Shs Float
365.28M
52W High
176.66 -17.85%
52W Low
22.28 551.39%
Volatility
20.64% 9.79%
ATR (14)
14.89
RSI (14)
71.60
Beta
1.02
Rel Volume
7.63
Avg Volume
11.44M
Volume
87,316,065
Perf Week
129.20%
Perf Month
154.52%
Perf Quarter
207.09%
Perf Half Y
191.02%
Perf YTD
392.13%
Perf Year
453.51%
Perf 3Y
30.65%
Perf 5Y
-62.11%
Perf 10Y
-
Prev Close
133.32
Price
145.13
Change %
8.86%
Date Action Analyst Rating Change Price Target Change
Aug-19-26Upgrade William Blair Mkt Perform → Outperform
Aug-19-26Upgrade BofA Securities Underperform → Neutral
Jan-28-26Resumed Barclays Equal Weight $25
Jan-07-26Resumed UBS Neutral $34
Dec-12-25Initiated Jefferies Hold $30
Mar-13-25Initiated Citigroup Neutral $40
Feb-18-25Downgrade Barclays Overweight → Equal Weight $111 → $45
Jan-29-25Downgrade Goldman Buy → Neutral $99 → $51
Dec-18-24Downgrade Argus Buy → Hold
Dec-10-24Resumed BofA Securities Underperform $41
Aug-21-26 08:00PM
06:14PM
05:59PM
05:19PM
04:13PM
02:57PM Loading…
02:57PM
02:54PM
02:26PM
02:15PM
10:54AM
10:37AM
08:08AM
07:18AM
07:09AM
07:03AM
06:00AM Loading…
06:00AM
04:20AM
04:07AM
Aug-20-26 10:46PM
07:55PM
04:20PM
04:18PM
04:03PM
03:43PM
03:20PM
03:01PM
02:37PM
02:36PM
02:21PM
02:16PM
01:26PM Loading…
01:26PM
01:22PM
12:51PM
12:44PM
12:43PM
11:51AM
11:42AM
11:30AM
10:58AM
10:15AM
10:06AM
10:02AM
09:46AM
08:10AM
07:31AM
06:57AM
06:44AM
06:36AM
06:01AM
05:59AM
05:32AM
05:10AM
04:58AM
03:32AM
12:05AM
Aug-19-26 10:43PM
10:20PM
08:34PM
07:55PM
07:33PM
06:37PM
06:21PM
05:34PM
05:23PM
04:35PM
04:35PM
04:25PM
04:01PM
03:38PM
03:38PM
02:54PM
02:29PM
02:07PM
02:06PM
01:52PM
01:49PM
01:37PM
01:30PM
01:23PM
01:19PM
12:54PM
12:53PM
12:13PM
12:00PM
11:51AM
11:48AM
11:41AM
11:16AM
11:15AM
10:46AM
10:43AM
10:38AM
10:34AM
10:16AM
10:14AM
10:09AM
09:39AM
09:38AM
09:29AM
08:28AM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
CEO & DirectorMr. Stephane Bancel M.B.A.
PresidentDr. Stephen Hoge M.D.
Chief Financial OfficerMr. James M. Mock
Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger J.D.
Chief Technical Operations & Quality OfficerDr. Jerh Collins Ph.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bancel StephaneChief Executive OfficerAug 05 '26Option Exercise19.15499,2469,560,5616,687,037Aug 07 04:11 PM
Bancel StephaneChief Executive OfficerAug 06 '26Option Exercise19.15252,4694,834,7816,440,260Aug 07 04:11 PM
Bancel StephaneChief Executive OfficerAug 05 '26Sale57.52499,24628,715,0116,187,791Aug 07 04:11 PM
Bancel StephaneOfficerAug 05 '26Proposed Sale58.00499,24628,956,268Aug 05 01:02 PM
Hoge StephenPresidentJul 15 '26Option Exercise19.1553,3361,021,3841,537,184Jul 16 04:45 PM
Hoge StephenPresidentJul 15 '26Sale67.6053,3363,605,5141,483,848Jul 16 04:45 PM
Hoge StephenOfficerJul 15 '26Proposed Sale67.6053,3363,605,514Jul 15 10:22 AM
SAGAN PAULFormer DirectorJun 18 '26Proposed Sale64.5725,7701,663,875Jun 18 03:26 PM
Hoge StephenPresidentJun 15 '26Option Exercise19.1553,3361,021,3841,537,184Jun 17 04:10 PM
Hoge StephenPresidentJun 15 '26Sale51.3753,3362,739,8701,483,848Jun 17 04:10 PM
Hoge StephenOfficerJun 15 '26Proposed Sale51.3753,3362,739,870Jun 15 11:43 AM
Klinger Shannon ThymeChief Legal OfficerJun 04 '26Option Exercise30.963,471107,46270,939Jun 08 04:34 PM
Klinger Shannon ThymeChief Legal OfficerJun 04 '26Sale50.003,471173,55067,468Jun 08 04:34 PM
Klinger Shannon ThymeOfficerJun 04 '26Proposed Sale50.003,471173,550Jun 04 01:26 PM
AFEYAN NOUBARDirectorMay 21 '26Option Exercise19.159,263177,38613,187May 22 07:00 PM
AFEYAN NOUBARDirectorMay 21 '26Sale46.849,263433,8793,924May 22 07:00 PM
Flagship Pioneering, LLCAffiliateMay 21 '26Proposed Sale46.849,263433,880May 21 03:06 PM
Hoge StephenPresidentMay 15 '26Option Exercise19.1553,3361,021,3841,531,333May 18 04:57 PM
Hoge StephenPresidentMay 15 '26Sale48.4053,3362,581,4621,477,997May 18 04:57 PM
Hoge StephenOfficerMay 15 '26Proposed Sale48.4053,3362,581,462May 15 09:47 AM
SAGAN PAULFormer DirectorMay 08 '26Proposed Sale54.4836,7592,002,787May 08 11:24 AM
Hussain AbbasDirectorMay 01 '26Sale46.635,682264,95212,066May 04 05:25 PM
Hussain AbbasDirectorMay 01 '26Proposed Sale46.635,682264,952May 01 11:44 AM
Klinger Shannon ThymeChief Legal OfficerMar 02 '26Option Exercise30.9613,885429,88073,574Mar 03 04:10 PM
Klinger Shannon ThymeChief Legal OfficerMar 02 '26Sale52.2913,885726,04759,689Mar 03 04:10 PM
Klinger Shannon ThymeOfficerMar 02 '26Proposed Sale52.2913,885726,047Mar 02 09:56 AM
Hoge StephenPresidentFeb 23 '26Option Exercise19.15160,0093,064,1721,617,436Feb 25 04:49 PM
Hoge StephenPresidentFeb 23 '26Sale48.84160,0097,814,8401,457,427Feb 25 04:49 PM
Hoge StephenOfficerFeb 23 '26Proposed Sale48.84160,0097,814,840Feb 23 10:26 AM
AFEYAN NOUBARDirectorDec 11 '25Option Exercise10.9023,853259,99827,777Dec 15 09:00 AM
AFEYAN NOUBARDirectorDec 11 '25Sale29.4823,853703,3063,924Dec 15 09:00 AM
Bancel StephaneChief Executive OfficerDec 11 '25Option Exercise10.90688,0737,499,9966,181,970Dec 15 08:59 AM
Flagship Pioneering Inc.AffiliateDec 11 '25Proposed Sale29.4923,853703,306Dec 11 04:30 PM
Hussain AbbasDirectorDec 09 '25Sale27.6050413,9101,515Dec 11 04:16 PM
Hussain AbbasDirectorDec 09 '25Proposed Sale27.6050413,910Dec 09 10:26 AM